Retatrutide 5mg
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, currently under investigation for its role in metabolic research. Each vial contains 5mg of lyophilised peptide.
High-purity peptides supplied exclusively to Australian customers via domestic Express Post.
Research Peptides
Prices in AUD. Add $15 for Australia Post Domestic Express Post Shipping.
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, currently under investigation for its role in metabolic research. Each vial contains 5mg of lyophilised peptide.
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, under active investigation for metabolic and weight-management research. Each vial contains 10mg of lyophilised peptide.
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, under active investigation for metabolic and weight-management research. Each vial contains 20mg of lyophilised peptide.
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, under active investigation for metabolic and weight-management research. Each vial contains 30mg of lyophilised peptide.
Tirzepatide is a dual GLP-1 and GIP receptor agonist studied for its effects on glucose metabolism and body composition. Each vial contains 10mg of lyophilised peptide.
Tirzepatide is a dual GLP-1 and GIP receptor agonist studied for its effects on glucose metabolism and body composition. Each vial contains 20mg of lyophilised peptide.
Tirzepatide is a dual GLP-1 and GIP receptor agonist studied for its effects on glucose metabolism and body composition. Each vial contains 30mg of lyophilised peptide.
MOTS-C is a mitochondrial-derived peptide encoded in the 12S rRNA region of the mitochondrial genome. It is studied for its roles in metabolic homeostasis, insulin sensitivity, and cellular stress responses. Each vial contains 40mg.
SS-31 (Elamipretide) is a cell-permeable, mitochondria-targeted tetrapeptide studied for its ability to stabilise cardiolipin and reduce mitochondrial oxidative stress in ageing and disease models. Each vial contains 50mg.
AOD-9604 is a modified fragment of human growth hormone (hGH) spanning residues 176–191, investigated for its lipolytic properties and metabolic effects without the proliferative actions of full hGH. Each vial contains 10mg.
Cagrilintide is a long-acting amylin analogue under investigation for its role in appetite regulation and metabolic control, often studied in combination with GLP-1 receptor agonists. Each vial contains 10mg.
Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone that mimics LH activity. It is widely used in research contexts relating to gonadal function, steroidogenesis, and reproductive biology. Each vial contains 5000IU.
GHK-Cu (copper peptide) is a naturally occurring tripeptide-copper complex studied for its roles in wound healing, collagen synthesis, antioxidant activity, and tissue remodelling. Each vial contains 50mg.
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist, valued in research for its clean GH release profile with minimal impact on cortisol or prolactin. Each vial contains 10mg.
BPC-157 is a synthetic pentadecapeptide derived from a protective gastric protein, extensively studied for its cytoprotective, angiogenic, and tissue-repair properties across multiple organ systems. Each vial contains 10mg.
TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring peptide involved in actin regulation. It is researched for its role in tissue repair, angiogenesis, and inflammation modulation. Each vial contains 10mg.
KLOW is a proprietary peptide blend formulated for research into metabolic and body composition pathways. Each vial contains 80mg of lyophilised blend.
GLOW is a proprietary peptide blend developed for research applications relating to skin biology, collagen pathways, and cellular regeneration. Each vial contains 70mg of lyophilised blend.
GHK-Cu (copper peptide) is a naturally occurring tripeptide-copper complex studied for its roles in wound healing, collagen synthesis, antioxidant activity, and tissue remodelling. Each vial contains 100mg.
Tesamorelin is a stabilised GHRH analogue investigated for its effects on visceral adipose tissue reduction and GH axis modulation in research models. Each vial contains 10mg of lyophilised peptide.
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analogue investigated for sustained growth hormone release in research models. Each vial contains 5mg of lyophilised peptide.
A research blend combining CJC-1295 (without DAC) and Ipamorelin, two complementary growth hormone secretagogues studied for their synergistic effect on pulsatile GH release. Each vial contains 10mg.
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), studied for its role in fat cell metabolism, NAD⁺ regulation, and adipogenesis suppression in preclinical research. Each vial contains 50mg.
Kisspeptin is a hypothalamic neuropeptide that plays a key regulatory role in the HPG axis, acting as a potent stimulator of GnRH release. It is studied in reproductive endocrinology and neuroendocrine research. Each vial contains 10mg.
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), comprising the first 29 amino acids. It is widely studied for its role in stimulating endogenous GH secretion. Each vial contains 10mg.
How It Works
Simple, safe and transparent from click to letterbox.
Browse our range and find the peptide you're after. Each listing includes full specs, purity and available quantities.
Contact us via Threema with the peptide name and quantity needed and a secure BTC payment address will be provided to you.
Peptides are securely packed in non-descript packaging and Express Posted with Australia Post.
Track your order end-to-end. Happy with your product? Leave us a review!
★★★★★
Hundreds of happy customers across Australia.
Don't just take our word for it — read what they say.